Literature DB >> 15145031

Diagnostic imaging of cystic pancreatic neoplasms.

Brendan C Visser1, V Raman Muthusamay, Sean J Mulvihill, Fergus Coakley.   

Abstract

Cystic pancreatic neoplasms are being diagnosed with growing frequency due to improving imaging technologies and increasing clinician awareness. Distinguishing cystic neoplasms from pseudocysts and discriminating among the various cystic neoplasms is essential to appropriate management. The backbone of diagnosis of these tumors continues to be cross-sectional imaging by CT and MRI. Despite refinements in technology and significant progress in characterizing these lesions, the overall accuracy of CT and MR is limited. EUS, especially as means of FNA, will have an increasing role in the evaluation of selected cases as experience grows. No radiologic investigation can reliably distinguish cystic neoplasms from pseudocysts nor differentiate among cystic neoplasms in all cases. For uncertain lesions, surgeons should favor either careful observation with serial imaging or surgical resection.

Entities:  

Mesh:

Year:  2004        PMID: 15145031     DOI: 10.1016/j.suronc.2004.01.002

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  10 in total

1.  Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma.

Authors:  Ji Kon Ryu; Hanno Matthaei; Marco Dal Molin; Seung-Mo Hong; Marcia I Canto; Richard D Schulick; Christopher Wolfgang; Michael G Goggins; Ralph H Hruban; Leslie Cope; Anirban Maitra
Journal:  Pancreatology       Date:  2011-07-12       Impact factor: 3.996

Review 2.  [Importance of endoscopy and endosonography for chronic pancreatitis and benign pancreas tumors].

Authors:  M Fuchs; W Schepp
Journal:  Radiologe       Date:  2008-08       Impact factor: 0.635

3.  The Role of Endoscopic Ultrasound in Cystic Pancreatic Tumor Treatment.

Authors:  Bhavani Moparty; Manoop S Bhutani
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-08

4.  Diagnosis of pancreatic tumors by endoscopic ultrasonography.

Authors:  Hiroki Sakamoto; Masayuki Kitano; Ken Kamata; Muhammad El-Masry; Masatoshi Kudo
Journal:  World J Radiol       Date:  2010-04-28

Review 5.  Cystic neoplasms of the pancreas.

Authors:  Hop S Tran Cao; Benjamin Kellogg; Andrew M Lowy; Michael Bouvet
Journal:  Surg Oncol Clin N Am       Date:  2010-04       Impact factor: 3.495

6.  The clinicopathologic features of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Xinyu Qin; Fenglin Liu
Journal:  Front Med China       Date:  2007-02-01

7.  Pancreatic serous cystadenoma with compression of the main pancreatic duct: an unusual entity.

Authors:  Stéphanie Truant; D Izgarevic; Vincent Maunoury; David Buob; Philippe Bulois; Olivier Ernst; Guillemette Huet; Philippe Zerbib; François-René Pruvot
Journal:  HPB Surg       Date:  2011-03-14

8.  Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsies.

Authors:  Adam E Frampton; Jonathan Krell; Mireia Mato Prado; Tamara M H Gall; Nima Abbassi-Ghadi; Giovanna Del Vecchio Blanco; Niccola Funel; Elisa Giovannetti; Leandro Castellano; Mohamed Basyouny; Nagy A Habib; Harry Kaltsidis; Panagiotis Vlavianos; Justin Stebbing; Long R Jiao
Journal:  Oncotarget       Date:  2016-05-10

9.  New criteria to differentiate between mucinous cystic neoplasm and serous cystic neoplasm in pancreas by endoscopic ultrasound: A preliminarily confirmed outcome of 41 patients.

Authors:  Wengang Zhang; Enqiang Linghu; Ningli Chai; Huikai Li
Journal:  Endosc Ultrasound       Date:  2017 Mar-Apr       Impact factor: 5.628

Review 10.  The Role of Positron Emission Tomography in Clinical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Simone Serafini; Cosimo Sperti; Alessandra Rosalba Brazzale; Diego Cecchin; Pietro Zucchetta; Elisa Sefora Pierobon; Alberto Ponzoni; Michele Valmasoni; Lucia Moletta
Journal:  Cancers (Basel)       Date:  2020-03-27       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.